Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib plus chemotherapy vs placebo plus chemotherapy in first-line squamous non-small cell lung cancer
CTR20191776Phase 3Active
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of folinic acid in Pulmonary squamous cell carcinoma, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Sep 2019; status: active.
02
Drugs
folinic acid
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on CTR20191776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191776.